Immatics (IMTX) Change in Acquisitions & Divestments (2022 - 2026)
Immatics (IMTX) posted Change in Acquisitions & Divestments of $34.7 million for Q4 2025, down 76.04% sequentially from $144.7 million in Q3 2025, and down 32.55% YoY from $51.4 million in Q4 2024.
Analysis
Immatics (IMTX) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Immatics has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $34.7 million in Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 32.55% year-over-year to $34.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $603.3 million (up 77.29% YoY) and the FY2025 annual result came in at $621.2 million, up 82.54% from the prior year.
- Change in Acquisitions & Divestments fell to $34.7 million in Q4 2025 per IMTX's latest filing, from $144.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $324.5 million in Q1 2025 and troughed at -$246.5 million in Q4 2023.
- A 4-year average of $68.6 million and a median of $71.9 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 1628.65% in 2023, then sank 33.4% in 2025.
- Over 4 years, Change in Acquisitions & Divestments stood at $6.1 million in 2022, then sank by 4152.08% to -$246.5 million in 2023, then soared by 120.84% to $51.4 million in 2024, then sank by 32.55% to $34.7 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $34.7 million, $144.7 million, and $99.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.01 Mn |
| Mar 31, 2026 | 50.02 Mn |
| Dec 31, 2025 | 34.65 Mn |
| Sep 30, 2025 | 144.65 Mn |
| Jun 30, 2025 | 99.40 Mn |
| Mar 31, 2025 | 324.55 Mn |
| Dec 31, 2024 | 51.38 Mn |
| Sep 30, 2024 | 76.67 Mn |
| Jun 30, 2024 | 149.25 Mn |
| Mar 31, 2024 | 62.96 Mn |
| Dec 31, 2023 | 199.25 Mn |
| Sep 30, 2023 | 70.35 Mn |
| Jun 30, 2023 | 105.18 Mn |
| Mar 31, 2023 | 73.35 Mn |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 7.85 Mn |